Literature DB >> 32367277

Clinical and Genetic Characterization of Autosomal Recessive Spinocerebellar Ataxia Type 16 (SCAR16) in Taiwan.

Hsu-Huai Chiu1,2, Cheng-Tsung Hsaio2,3,4, Yu-Shuen Tsai5,6, Yi-Chu Liao1,2,7, Yi-Chung Lee8,9,10, Bing-Wen Soong11,12,13,14,15.   

Abstract

Mutations in STUB1 have been identified to cause autosomal recessive spinocerebellar ataxia type 16 (SCAR16), also named as Gordon Holmes syndrome, which is characterized by cerebellar ataxia, cognitive decline, and hypogonadism. Additionally, several heterozygous mutations in STUB1 have recently been described as a cause of autosomal dominant spinocerebellar ataxia type 48. STUB1 encodes C-terminus of HSC70-interacting protein (CHIP), which functions as an E3 ubiquitin ligase and co-chaperone and has been implicated in several neurodegenerative diseases. In this study, we identified two SCAR16 pedigrees from 512 Taiwanese families with cerebellar ataxia. Two compound heterozygous mutations in STUB1, c.[433A>C];[721C>T] (p.[K145Q];[R241W]) and c.[433A>C];[694T>G] (p.[K145Q];[C232G]), were found in each SCAR16 family by Sanger sequencing, respectively. Among them, STUB1 p.R241W and p.C232G were novel mutations. SCAR16 seems to be an uncommon ataxic syndrome, accounting for 0.4% (2/512) of our cohort with cerebellar ataxia. Clinically, the three patients from the two SCAR16 families presented with cerebellar ataxia alone or in combination with cognitive impairment. The brain MRIs showed a marked cerebellar atrophy of the patients. In conclusion, SCAR16 is an important but often neglected diagnosis of cerebellar ataxia of unknown cause, and the isolated cerebellar ataxia without involvement of other systems cannot be a basis to exclude the possibility of STUB1-related disease.

Entities:  

Keywords:  CHIP; Cerebellar ataxia; Gordon Holmes syndrome; SCAR16; STUB1

Mesh:

Substances:

Year:  2020        PMID: 32367277     DOI: 10.1007/s12311-020-01136-4

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  5 in total

1.  Reply to STUB1-Related Ataxias: A Challenging Diagnosis.

Authors:  Diana A Olszewska; Justin A Kinsella
Journal:  Mov Disord Clin Pract       Date:  2020-07-19

Review 2.  CHIP as a therapeutic target for neurological diseases.

Authors:  Shuo Zhang; Zheng-Wei Hu; Cheng-Yuan Mao; Chang-He Shi; Yu-Ming Xu
Journal:  Cell Death Dis       Date:  2020-09-09       Impact factor: 8.469

3.  A Severe Dementia Syndrome Caused by Intron Retention and Cryptic Splice Site Activation in STUB1 and Exacerbated by TBP Repeat Expansions.

Authors:  Marlen Colleen Reis; Julia Patrun; Nibal Ackl; Pia Winter; Maximilian Scheifele; Adrian Danek; Dagmar Nolte
Journal:  Front Mol Neurosci       Date:  2022-04-14       Impact factor: 5.639

Review 4.  Mutations in Hsp90 Cochaperones Result in a Wide Variety of Human Disorders.

Authors:  Jill L Johnson
Journal:  Front Mol Biosci       Date:  2021-12-08

Review 5.  C-terminus of Hsp70 Interacting Protein (CHIP) and Neurodegeneration: Lessons from the Bench and Bedside.

Authors:  Sivakami Mylvaganam; Rebecca Earnshaw; Gregory Heymann; Suneil K Kalia; Lorraine V Kalia
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.